How Lymphotoxic Is Dose-Intensified Temozolomide? The Glioblastoma Experience

Publisher Website

20 June 2005

journal article
other
Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology

Vol. 23 (18) , 4235-4236
https://doi.org/10.1200/jco.2004.00.8417

Abstract

No abstract available

This publication has 2 references indexed in Scilit:

Predicting the extent of invasive disease by MRI to enhance the use of minimally invasive techniques in the management of early stage breast carcinoma
Journal of Clinical Oncology, 2004
One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma
Neurology, 2004